Shares of Nektar Therapeutics (NKTR) have been struggling lately and have lost 11.5% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...

Listen to Story Mohammed Shami was not picked in India's XI for the first T20I India picked only one frontline pacer in the series opener in Kolkata India won the toss and opted to field against ...

after batter failed to make ICC Champions Trophy 2025 squad THIS Punjab Kings pacer is on verge of creating history ahead of IPL 2025, needs just 2 wickets in T20 against England to ...

With the upcoming five-match T20I series against India, England will start their white-ball era under Brendon McCullum. Trending Photos England have announced their playing XI for the T20 ...

Kuldeep’s return following a hernia surgery and Ravindra Jadeja’s inclusion as the last name on the team sheet instead of Mohammed Siraj, a pacer, meant the selectors have preferred only three ...

Nektar Therapeutics Stock Performance NASDAQ:NKTR opened at $0.89 on Friday. Nektar Therapeutics has a 52-week low of $0.48 and a 52-week high of $1.93. The stock has a fifty day moving average of ...

The ace Indian pacer, who sustained a back injury during the final Test of the Border-Gavaskar Trophy in Sydney, is at the center of discussions as fans eagerly await updates on his recovery. In a ...

In a major blow for South Africa's hopes for the ICC Men's Champions Trophy 2025, key pacer Anrich Nortje has been ruled out with a back injury. The extent of the injury was revealed after the pacer ...

A similar incident took place during the Bangladesh Premier League 2024-25 on Sunday. It was Bangladesh pacer Tanzim Hasan Sakib, who did a Kohli by barging shoulders with Pakistan's Mohammad Nawaz.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders.